Skip to main content
Journal cover image

The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review.

Publication ,  Journal Article
Foster, M; Etchin, A; Pope, C; Hartmann, CW; Emidio, O; Bosworth, HB
Published in: Curr Hypertens Rep
November 2023

PURPOSE OF REVIEW: To conduct a scoping review of articles which examined the impact of COVID-19 on HTN and HTN medication adherence among underrepresented racial/ethnic minorities. RECENT FINDINGS: Seven studies were included in this review and impact of COVID-19 was examined at 4 levels: patient, provider, health system and society. The results indicated that patient level factors, such as high unemployment and inequitable access to telemedicine due to society factors- lack of access to high-speed Internet and variation in the offering of telehealth by health systems, were most impactful on adherence. Additionally, provider level clinical inertia may have further impacted adherence to HTN medication. Our review showed that the COVID-19 pandemic did not introduce new barriers but exacerbated preexisting barriers. Ongoing efforts are needed to change policies at the state and local levels to dismantle inequities in underrepresented communities to ensure access to health care with telemedicine to promote health equity.

Duke Scholars

Published In

Curr Hypertens Rep

DOI

EISSN

1534-3111

Publication Date

November 2023

Volume

25

Issue

11

Start / End Page

385 / 394

Location

United States

Related Subject Headings

  • Telemedicine
  • SARS-CoV-2
  • Hypertension
  • Humans
  • Healthcare Disparities
  • Health Services Accessibility
  • Ethnic and Racial Minorities
  • COVID-19
  • Assessment of Medication Adherence
  • Antihypertensive Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Foster, M., Etchin, A., Pope, C., Hartmann, C. W., Emidio, O., & Bosworth, H. B. (2023). The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review. Curr Hypertens Rep, 25(11), 385–394. https://doi.org/10.1007/s11906-023-01262-4
Foster, Marva, Anna Etchin, Charlene Pope, Christine W. Hartmann, Oluwabunmi Emidio, and Hayden B. Bosworth. “The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review.Curr Hypertens Rep 25, no. 11 (November 2023): 385–94. https://doi.org/10.1007/s11906-023-01262-4.
Foster M, Etchin A, Pope C, Hartmann CW, Emidio O, Bosworth HB. The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review. Curr Hypertens Rep. 2023 Nov;25(11):385–94.
Foster, Marva, et al. “The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review.Curr Hypertens Rep, vol. 25, no. 11, Nov. 2023, pp. 385–94. Pubmed, doi:10.1007/s11906-023-01262-4.
Foster M, Etchin A, Pope C, Hartmann CW, Emidio O, Bosworth HB. The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review. Curr Hypertens Rep. 2023 Nov;25(11):385–394.
Journal cover image

Published In

Curr Hypertens Rep

DOI

EISSN

1534-3111

Publication Date

November 2023

Volume

25

Issue

11

Start / End Page

385 / 394

Location

United States

Related Subject Headings

  • Telemedicine
  • SARS-CoV-2
  • Hypertension
  • Humans
  • Healthcare Disparities
  • Health Services Accessibility
  • Ethnic and Racial Minorities
  • COVID-19
  • Assessment of Medication Adherence
  • Antihypertensive Agents